Po-yen Chen

250 Wuxing St
Taipei, TNQ 11031, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Clesrovimab in Infants at Increased Risk For Severe Disease During 2 RSV Seasons: A Randomized Clinical Trial.

Clesrovimab in Infants at Increased Risk For Severe Disease During 2 RSV Seasons: A Randomized Clinical Trial.

Journal: JAMA pediatrics

Published: July 20, 2026

Ammonia toxicity in medaka embryos involves ion depletion and internal organ apoptosis and its mitigation is by sodium-driven ammonia excretion.

Ammonia toxicity in medaka embryos involves ion depletion and internal organ apoptosis and its mitigation is by sodium-driven ammonia excretion.

Journal: Comparative biochemistry and physiology. Toxicology & pharmacology : CBP

Published: March 02, 2026

A randomised trial of a bioreactor-produced EV-A71 vaccine for endemic control in children.

A randomised trial of a bioreactor-produced EV-A71 vaccine for endemic control in children.

Journal: NPJ vaccines

Published: October 10, 2025

Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease.

Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease.

Journal: The New England journal of medicine

Published: September 17, 2025

Recommendation for the use of respiratory syncytial virus vaccines.

Recommendation for the use of respiratory syncytial virus vaccines.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: October 10, 2024

Recommendation for immune prophylaxis of respiratory syncytial virus infection in children.

Recommendation for immune prophylaxis of respiratory syncytial virus infection in children.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: October 03, 2024

Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19.

Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19.

Journal: Frontiers in pediatrics

Published: March 06, 2023

Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial.

Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: December 22, 2021

Catecholamine-Induced Secondary Takotsubo Syndrome in Children With Severe Enterovirus 71 Infection and Acute Heart Failure: A 20-year Experience of a Single Institute.

Catecholamine-Induced Secondary Takotsubo Syndrome in Children With Severe Enterovirus 71 Infection and Acute Heart Failure: A 20-year Experience of a Single Institute.

Journal: Frontiers in cardiovascular medicine

Published: August 03, 2021

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study.

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study.

Journal: The Pediatric infectious disease journal

Published: July 21, 2021

COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.

COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.

Journal: Expert review of vaccines

Published: June 28, 2021

The epidemiological features of pediatric viral respiratory infection during the COVID-19 pandemic in Taiwan.

The epidemiological features of pediatric viral respiratory infection during the COVID-19 pandemic in Taiwan.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: April 30, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026